BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

665 related articles for article (PubMed ID: 20385637)

  • 1. Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts.
    Schneeweiss S; Patrick AR; Solomon DH; Dormuth CR; Miller M; Mehta J; Lee JC; Wang PS
    Pediatrics; 2010 May; 125(5):876-88. PubMed ID: 20385637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years' data.
    Schneeweiss S; Patrick AR; Solomon DH; Mehta J; Dormuth C; Miller M; Lee JC; Wang PS
    Arch Gen Psychiatry; 2010 May; 67(5):497-506. PubMed ID: 20439831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newer generation antidepressants for depressive disorders in children and adolescents.
    Hetrick SE; McKenzie JE; Cox GR; Simmons MB; Merry SN
    Cochrane Database Syst Rev; 2012 Nov; 11(11):CD004851. PubMed ID: 23152227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
    Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Safety of selective serotonin reuptake inhibitor antidepressants in children and adolescents].
    Bailly D
    Presse Med; 2006 Oct; 35(10 Pt 2):1507-15. PubMed ID: 17028514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressants and the risk of suicidal behaviors.
    Jick H; Kaye JA; Jick SS
    JAMA; 2004 Jul; 292(3):338-43. PubMed ID: 15265848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
    Hjalmarsson L; Corcos M; Jeammet P
    Encephale; 2005; 31(3):309-16. PubMed ID: 16142045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.
    Hetrick S; Merry S; McKenzie J; Sindahl P; Proctor M
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004851. PubMed ID: 17636776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study.
    Brent DA; Emslie GJ; Clarke GN; Asarnow J; Spirito A; Ritz L; Vitiello B; Iyengar S; Birmaher B; Ryan ND; Zelazny J; Onorato M; Kennard B; Mayes TL; Debar LL; McCracken JT; Strober M; Suddath R; Leonard H; Porta G; Keller MB
    Am J Psychiatry; 2009 Apr; 166(4):418-26. PubMed ID: 19223438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort.
    Tiihonen J; Lönnqvist J; Wahlbeck K; Klaukka T; Tanskanen A; Haukka J
    Arch Gen Psychiatry; 2006 Dec; 63(12):1358-67. PubMed ID: 17146010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal complications after intrauterine exposure to SSRI antidepressants.
    Prescrire Int; 2004 Jun; 13(71):103-4. PubMed ID: 15233148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dosing of Selective Serotonin Reuptake Inhibitors Among Children and Adults Before and After the FDA Black-Box Warning.
    Bushnell GA; Stürmer T; Swanson SA; White A; Azrael D; Pate V; Miller M
    Psychiatr Serv; 2016 Mar; 67(3):302-9. PubMed ID: 26567938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions.
    Mandrioli R; Mercolini L; Saracino MA; Raggi MA
    Curr Med Chem; 2012; 19(12):1846-63. PubMed ID: 22414078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The treatment of SSRI-resistant depression in adolescents (TORDIA): in search of the best next step.
    Brent DA
    Depress Anxiety; 2009; 26(10):871-4. PubMed ID: 19798756
    [No Abstract]   [Full Text] [Related]  

  • 15. Antidepressants and suicide attempts in children.
    Cooper WO; Callahan ST; Shintani A; Fuchs DC; Shelton RC; Dudley JA; Graves AJ; Ray WA
    Pediatrics; 2014 Feb; 133(2):204-10. PubMed ID: 24394688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant class, age, and the risk of deliberate self-harm: a propensity score matched cohort study of SSRI and SNRI users in the USA.
    Miller M; Pate V; Swanson SA; Azrael D; White A; Stürmer T
    CNS Drugs; 2014 Jan; 28(1):79-88. PubMed ID: 24146116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin reuptake inhibitor antidepressants and pregnancy: many unanswered questions.
    Prescrire Int; 1999 Oct; 8(43):157-9. PubMed ID: 11503843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDA questions antidepressant safety for children.
    Oransky I
    Lancet; 2003 Nov; 362(9395):1558. PubMed ID: 14627000
    [No Abstract]   [Full Text] [Related]  

  • 19. Suicide prevention and serotonergic drugs.
    Montgomery SA
    Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():83-5. PubMed ID: 8201249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective study of fluoxetine treatment and suicidal behavior in affectively ill subjects.
    Leon AC; Keller MB; Warshaw MG; Mueller TI; Solomon DA; Coryell W; Endicott J
    Am J Psychiatry; 1999 Feb; 156(2):195-201. PubMed ID: 9989554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.